Episodes

  • The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection?

    The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection?
    Apr 7 2026
    Join AI host Julia Cartwright as she compares Foundayo, the FDA-approved daily GLP-1 pill, with injectable Wegovy. We examine clinical trial data showing Foundayo's 12.4% weight loss versus Wegovy's 15-16%, discuss medication adherence challenges, switching protocols, and explore who benefits most from each option in this evolving weight management landscape.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    26 mins
  • The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution

    The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution
    Apr 7 2026
    Julia Cartwright explores how oral GLP-1 medications transformed obesity treatment access in 2026. Oral Wegovy and Foundayo launched at $25-$149 monthly, eliminating needles and cost barriers that kept 90% of eligible patients untreated. With 170,000 prescriptions in three weeks and home delivery options, the access revolution began reshaping healthcare for millions.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    30 mins
  • The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For?

    The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For?
    Apr 7 2026
    Julia Cartwright explores Foundayo, the FDA-approved daily GLP-1 pill that offers a needle-free alternative for weight management. She examines who truly benefits from this $149/month medication—addressing barriers of cost, needle aversion, and accessibility that keep 90% of eligible patients untreated, while honestly comparing its effectiveness to injectable options.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    27 mins